Funded by Volleyball, Breast Cancer Pilot Study Succeeds
Article written by: Michele McDonald at George Mason University Funded by volleyball teams nationwide, a new study released this week shows success in pinpointing individualized treatment for women with metastatic breast cancer, according to George Mason University researchers. The Side-Out Foundation’s pilot study is part of a cutting-edge approach to personalized medicine that looks beyond […]
I-SPY 2 Trial Progress Report
June 20, 2012 — The Center for Applied Proteomics (CAPMM) at George Mason University recently released a progress report on its work with the I-SPY 2 trial. The Side-Out Foundation is hopeful that its support of the trial will affect the future of breast cancer treatments. I-SPY 2 Protein Pathway Activation Mapping to Uncover New […]
Big Meeting in Maui
On July 22-25, 2009 the Eighth International Congress on the Future of Breast Cancer will be held in Maui, Hawaii. Dr. Lance Liotta who is a lead researcher in the Side-Out Clinical Trial, will be a featured speaker in the segment “Toward Personalized Breast Cancer Therapies”. His presentation is titled Deciphering the Dominant Signaling Pathways: […]
